Enovis ENOV

Enovis Corporation is a medical technology company focused on developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows by manufacturing and distributing high-quality medical devices for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company addresses the continuum of patient care from injury prevention to rehabilitation after surgery or injury or from degenerative disease, enabling people to regain or maintain their natural motion. Enovis leverages its Enovis Growth Excellence business system (EGX) as a set of tools, processes, and culture to continuously improve its ability to enable great patient outcomes and drive growth. EGX incorporates the company’s values and drives behaviors through repeatable, teachable processes that create superior value for customers, shareholders, and associates. Each year, Enovis associates develop strategic and operating plans based on the Voice of the Customer principle, using EGX tools to deliver world-class quality, delivery, cost, and innovation.

Enovis generates revenue by developing, manufacturing, and distributing medical devices and related products across its two reportable segments. The company serves orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. Additionally, many of its non-surgical medical devices and accessories are used by athletes and patients for injury prevention and at-home physical therapy treatment. Revenue is derived from multiple distribution channels, including independent distributors and direct salespeople, reaching customers in various patient treatment settings and retail consumer markets. The company’s product portfolio supports both surgical and non-surgical care pathways, contributing to diversified revenue streams.

The company operates through the following segments: Prevention & Recovery and Reconstructive.

• Prevention & Recovery: This segment includes products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. Many of the non-surgical medical devices and related accessories are used by athletes and patients for injury prevention and at-home physical therapy treatment. The P&R product lines include rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems, compression garments, and electrical stimulators used for pain management and physical therapy.
• Reconstructive: This segment is a global medical technology business focused on developing, manufacturing, marketing, and distributing innovative surgical solutions that restore mobility and improve patient outcomes. The portfolio includes a broad range of differentiated implants, instrumentation, and enabling technologies used in elective and non-elective joint replacement, limb reconstruction, and foot & ankle procedures. Enovis serves orthopedic surgeons and healthcare systems worldwide with products for shoulder, hip, knee, and extremity reconstruction and fixation, including both primary and revision procedures. The offerings are supported by proprietary surgical techniques, surgeon education, and digital tools that enhance preoperative planning, intraoperative precision, and postoperative recovery.

Enovis competes in highly competitive and fragmented markets for both its Prevention & Recovery and Reconstructive segments. The principal elements of competition are innovation to create better patient outcomes, product quality, product reliability, brand names, and price. Key competitors for the Prevention & Recovery segment include Össur and Breg, Inc. For the Reconstructive segment, the company competes with large companies such as Stryker, Zimmer Biomet, and DePuy Synthes, the medical device business within Johnson & Johnson, as well as numerous smaller niche companies. Despite facing competitors with greater financial and marketing resources, Enovis believes its history of innovation and experienced management team enable it to effectively compete. The company views itself as a leading competitor in each of its markets with leading and well-recognized brands.

Enovis reaches a diverse customer base through multiple distribution channels, including independent distributors and direct salespeople. The company provides medical devices and related products to orthopedic specialists and other healthcare professionals operating in a variety of patient treatment settings. Additionally, many of its non-surgical medical devices and accessories are used by athletes and patients for injury prevention and at-home physical therapy treatment. The customer base includes healthcare providers in clinical environments and retail consumers seeking preventive and rehabilitative care solutions.